Welcome to Peptide Card of AntiTbPdb
This page displays user query in tabular form. |
KKLALALAKKWLALAKKLALALAKK details |
Primary information | |
---|---|
ID | antitb_1408, |
Name | 25154927 |
N-Terminal modification | D-LAK120-A |
C-Terminal Modification | KKLALALAKKWLALAKKLALALAKK |
Chemical Modification | Free |
Linear/Cyclic | Free |
Length | None |
Chirality | Linear |
Nature | 25 |
Source | L |
Origin | Cationic |
Species | Synthetic |
Inhibition Concentration | Mycobacterium tuberculosis |
In Vitro/ In vivo | Mycobacterium tuberculosis MDR strain |
Cell Line | MIC = 25 μM |
Inhibition Concentration | in vitro |
Sequence | 2014 |
Cytotoxicity | NA |
In vivo Model | NA |
Lethal Dose | NA |
Immune Responce | NA |
Mechanism of Action | NA |
Target | NA |
Combination Therapy | NA |
Other activities | NA |
PMID | NA |
Year of Publication | NA |
Tertiary Structure (Technique) | Not Predicted), |
Primary information | |
---|---|
ID | antitb_1413, |
Name | 25154927 |
N-Terminal modification | D-LAK120-A |
C-Terminal Modification | KKLALALAKKWLALAKKLALALAKK |
Chemical Modification | Free |
Linear/Cyclic | Free |
Length | None |
Chirality | Linear |
Nature | 25 |
Source | L |
Origin | Cationic |
Species | Synthetic |
Inhibition Concentration | Mycobacterium tuberculosis |
In Vitro/ In vivo | Mycobacterium tuberculosis XDR strain |
Cell Line | MIC = 100 μM |
Inhibition Concentration | in vitro |
Sequence | 2014 |
Cytotoxicity | NA |
In vivo Model | NA |
Lethal Dose | NA |
Immune Responce | NA |
Mechanism of Action | NA |
Target | NA |
Combination Therapy | NA |
Other activities | NA |
PMID | NA |
Year of Publication | NA |
Tertiary Structure (Technique) | Not Predicted), |
Primary information | |
---|---|
ID | antitb_1419, |
Name | 25154927 |
N-Terminal modification | D-LAK120-A |
C-Terminal Modification | KKLALALAKKWLALAKKLALALAKK |
Chemical Modification | Free |
Linear/Cyclic | Free |
Length | None |
Chirality | Linear |
Nature | 25 |
Source | L |
Origin | Cationic |
Species | Synthetic |
Inhibition Concentration | Mycobacterium tuberculosis |
In Vitro/ In vivo | Mycobacterium tuberculosis XDR strain |
Inhibition Concentration | in vitro |
Sequence | 2014 |
Cytotoxicity | THP-1 cell line |
In vivo Model | EC50 = 31.9 ± 9.5 μM |
Lethal Dose | Cytotoxic at > 25 μM |
Immune Responce | NA |
Mechanism of Action | NA |
Target | NA |
Combination Therapy | NA |
Other activities | NA |
PMID | NA |
Year of Publication | NA |
Tertiary Structure (Technique) | Not Predicted), |
Primary information | |
---|---|
ID | antitb_1425, |
Name | 25154927 |
N-Terminal modification | D-LAK120-A |
C-Terminal Modification | KKLALALAKKWLALAKKLALALAKK |
Chemical Modification | Free |
Linear/Cyclic | Free |
Length | None |
Chirality | Linear |
Nature | 25 |
Source | L |
Origin | Cationic |
Species | Synthetic |
Inhibition Concentration | Mycobacterium tuberculosis |
In Vitro/ In vivo | Mycobacterium tuberculosis MDR strain GB2 |
Inhibition Concentration | Ex vivo |
Sequence | 2014 |
Cytotoxicity | THP-1 cell line |
In vivo Model | NA |
Lethal Dose | Cytotoxic at12.5 μM |
Immune Responce | NA |
Mechanism of Action | NA |
Target | NA |
Combination Therapy | NA |
Other activities | NA |
PMID | NA |
Year of Publication | NA |
Tertiary Structure (Technique) | Not Predicted), |
Primary information | |
---|---|
ID | antitb_1429, |
Name | 25154927 |
N-Terminal modification | D-LAK120-A |
C-Terminal Modification | KKLALALAKKWLALAKKLALALAKK |
Chemical Modification | Free |
Linear/Cyclic | Free |
Length | None |
Chirality | Linear |
Nature | 25 |
Source | L |
Origin | Cationic |
Species | Synthetic |
Inhibition Concentration | Mycobacterium tuberculosis |
In Vitro/ In vivo | Mycobacterium tuberculosis XDR strain WYC-11 |
Inhibition Concentration | Ex vivo |
Sequence | 2014 |
Cytotoxicity | THP-1 cell line |
In vivo Model | NA |
Lethal Dose | Cytotoxic at12.5 μM |
Immune Responce | NA |
Mechanism of Action | NA |
Target | NA |
Combination Therapy | NA |
Other activities | NA |
PMID | NA |
Year of Publication | NA |
Tertiary Structure (Technique) | Not Predicted), |